Stoke Therapeutics Stock Forecast
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 24.05 +0.42%
STOK analyst consensus
Consensus (14 analysts)
strong_buy
Avg. price target
$46.46+93.99%
- Strong buy 2
- Buy 12
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 14 Wall Street analysts covering Stoke Therapeutics (2026-10-08), 14 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $46.46, with a high estimate of $60.00 and a low estimate of $35.00. The average target implies upside of 94.0% from the current price of $23.95.
The spread between the highest and lowest targets is 71.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for STOK.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 14% |
| Buy | 12 | 86% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $35.00 | +46.14% |
| Average target | $46.46 | +93.99% |
| High target | $60.00 | +150.52% |